Novan Inc 's ability to collect its outstanding accounts receivable from its corporate clients, has improved in the first quarter 2023 to a ratio of 1.45, this represents a new company high. This is a clear indication for improving liquidity at Novan Inc 's clients. Average receivable collection period, for the Novan Inc in Mar 31 2023 quarter, has decreased to 252 days, compared to 274 days, in the Dec 31 2022 quarter.

If we take a look into Healthcare sector 606 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Mar 31 2023 from 2902 to 3772.

What is Receivable Turnover Ratio?
What is Novan Inc Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

NOVN Receivables Turnover Ratio	(Mar 31 2023) I. Quarter	(Dec 31 2022) IV. Quarter	(Sep 30 2022) III. Quarter	(Jun 30 2022) II. Quarter	(Mar 31 2022) I. Quarter
Y / Y Receivable Change	-13.6 %	-	-	-	-
Y / Y Revenue Change	64.21 %	1500.15 %	594.03 %	724.36 %	135.41 %
Receivable Turnover Ratio (TTM)	1.45	1.33	1.13	1.11	1.02
NOVN's Total Ranking	# 3772	# 2902	# 3710	# 3214	# 3076
Accounts Receivable average collection period days	252	274	323	330	359
Seq. Receivable Change	-37.11 %	47.84 %	-18.31 %	13.76 %	-
Seq. Revenue Change	-69.79 %	104.91 %	-16.94 %	219.4 %	194.35 %

Receivable Turnover Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	# 229
Healthcare Sector	# 607
Overall Market	# 3772

Receivable Turnover Ratio Statistics
High	Average	Low
1.45	1.21	1.02
(Mar 31 2023)		(Mar 31 2022)

NOVN Company Profile • Back to NOVN Efficiency Comparisons • Compare NOVN Receivables Turnover Ratio to its Competitors

Financial Statements
Novan Inc 's Accounts Receivable	$ 14 Millions	Visit NOVN's Balance sheet
Novan Inc 's Sales TTM	$ 25 Millions	Visit NOVN's Income Statement
Sources of NOVN's Revenues		Visit NOVN's Sales by Geography

Other Accounts Receivable Turnover Ratios
Major Pharmaceutical Preparations Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
NOVN's Receivable Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
NOVN's Growth Rates	NOVN's Roa	NOVN's Inventory Turnover Ratio	NOVN's Dividend Comparisons
NOVN's Profitability Ratios	NOVN's Roi	NOVN's Asset Turnover Ratio	NOVN's Dividend Growth
NOVN's Valuation Ratios	NOVN's Roe	NOVN's Financial Strength Ratios	NOVN's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Mar 31 2023, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Mar 31 2023	Receivable at quarter ending Mar 31 2023
Therapeutic Solutions International Inc	4.94	$ 0.145 Millions	$ 0.029 Millions
Dyadic International Inc	4.94	$ 3.260 Millions	$ 0.660 Millions
Reshape Lifesciences Inc	4.94	$ 11.087 Millions	$ 2.246 Millions
Evoke Pharma Inc	4.93	$ 2.901 Millions	$ 0.588 Millions
Guardion Health Sciences Inc	4.93	$ 9.549 Millions	$ 1.937 Millions
Seelos Therapeutics inc	4.89	$ 0.970 Millions	$ 0.198 Millions
Lantheus Holdings Inc	4.89	$ 1,026.965 Millions	$ 209.957 Millions
Dexcom Inc	4.88	$ 3,022.500 Millions	$ 618.750 Millions
Labcorp Holdings Inc	4.88	$ 14,755.100 Millions	$ 3,023.450 Millions
Teva Pharmaceutical Industries Limited	4.86	$ 14,925.000 Millions	$ 3,068.000 Millions
Axsome Therapeutics Inc	4.86	$ 144.613 Millions	$ 29.741 Millions
Establishment Labs Holdings Inc	4.86	$ 169.772 Millions	$ 34.930 Millions
Healthcare Services Group Inc	4.86	$ 1,680.595 Millions	$ 346.043 Millions
Mirum Pharmaceuticals Inc	4.85	$ 95.768 Millions	$ 19.746 Millions
Bionik Laboratories Corp	4.84	$ 1.805 Millions	$ 0.373 Millions
Neurocrine Biosciences Inc	4.84	$ 1,598.500 Millions	$ 330.450 Millions
Staar Surgical Co	4.83	$ 294.719 Millions	$ 61.045 Millions
Bionano Genomics Inc	4.82	$ 29.521 Millions	$ 6.121 Millions
Caredx Inc	4.80	$ 319.639 Millions	$ 66.547 Millions
Artivion Inc	4.79	$ 319.805 Millions	$ 66.722 Millions
Ontrak Inc	4.78	$ 11.785 Millions	$ 2.464 Millions
Asensus Surgical Inc	4.77	$ 6.997 Millions	$ 1.466 Millions
Amgen Inc	4.77	$ 26,190.000 Millions	$ 5,488.000 Millions
Skinhealth Systems Inc	4.77	$ 376.739 Millions	$ 78.952 Millions
Caribou Biosciences Inc	4.76	$ 14.689 Millions	$ 3.084 Millions
Bristol myers Squibb Company	4.75	$ 45,848.000 Millions	$ 9,651.750 Millions
Maxcyte inc	4.74	$ 41.250 Millions	$ 8.704 Millions
G1 Therapeutics Inc	4.74	$ 57.345 Millions	$ 12.107 Millions
Capforce Inc	4.72	$ 3.051 Millions	$ 0.646 Millions
Transmedics Group Inc	4.71	$ 119.133 Millions	$ 25.311 Millions

Date modified: 2026-09-08T15:10:57+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.